Amir Safavi
@safaviaa
Radiation Oncology Fellow @MSKCancerCenter 🔜 Clinician Investigator & Assistant Professor @UofTDRO @Sunnybrook | via @PMCancerCentre @Columbia
ID: 3013396533
03-02-2015 00:12:43
5,5K Tweet
970 Followers
556 Following
The results of this study, led by Kara M. Ruicci, MD, PhD, are mind-boggling. While most clinical trials of systemic therapy for NSCLC, including many randomized phase II and III studies, allow for on-trial RT (off protocol), NONE (0%) of them actually collect any data on this
David Routman presents Mayo Clinic Comprehensive Cancer Center proposed changes to AJCC 8 staging that incorporates ENE status for #HPV OPC at #ASTRO25.
This week during #ASTRO2025, we hosted our second PULSAR Consortium Meeting. Thank you to everyone who joined us for this successful event! A special thank you to our moderator, Dr. Percy Lee MD, and our speakers: Drs. Robert Timmerman, Asal Rahimi M.D., M.S., Nancy Lee, and Zhen Zhang.
Another great month of accrual to NRG Oncology #HN014 #C-PRE for patients with advanced, resectable #skin #CSCC cancer. Excited for 🇦🇺 and 🇨🇦 to join the fight!🚀 NCI Cancer Control Trans Tasman Radiation Oncology Group CCTG Regeneron #OncSurgery MD Anderson Cancer Center
Terrific thread by Sean McBride While it is important to keep an open mind when faced with bizarre results, the raw survival numbers are almost incomprehensible. In the ITT population: - In the IMRT arm, there were 29 recurrences (Table 1) and 23 deaths due to cancer (Table
🔥Hot off the press: Patterns of care in de-novo oligo-metastatic and oligo-recurrent head and neck cancers: A Head and Neck Cancer International Group (HNCIG) Survey. authors.elsevier.com/c/1lt874tFDIRk… An Head and Neck Cancer International Group Young Investigator survey initiated by Monali Swain and Petr Szturz.
Here's another new ARREST2 case - 10 lung lesions (also liver lesions treated by Tim Nguyen not shown). Most of these will receive 20 Gy in 1 fraction, the ones adjacent to important structures get 35/5.
The most urgent person usually wins. —Kara Lawson, head coach Duke Women’s Basketball
🧵1/4 PATH study(Cohort A) out in IJROBP - The Red Journal – Our trial asks whether undetectable post-operative HPV ctDNA can select OPC candidates for adj RT omission and found high rates of disease recurrence #radonc #hncsm redjournal.org/article/S0360-…
Thread 1/14 🧵 New in Clinical Cancer Research: Our perspective on amphiregulin (AREG) as both a PREDICTIVE BIOMARKER and THERAPEUTIC TARGET following stereotactic radiotherapy (SBRT) in metastatic cancer. What makes this clinically actionable? Let's dive in.